Palantir CEO Alex Karp speaks during an interview on July 27, 2026 in New York City. John Lamparski | Getty Images Palantir stock rocketed 27% higher on Tuesday after the company reported “otherworldly” second-quarter earnings driven by customer demand for AI sovereign tools. The enterprise software giant reported a 93% growth in overall revenue to…
PayPal (PYPL +0.05%) recently turned down an offer to be acquired by Stripe and Advent for $60.50 a share, and that looks like a smart move. While the stock has been decimated, losing 80% of its value over the past five years, the company is still growing its revenue. Its valuation is very cheap, with…
Asian stock markets fell across the board on Friday as intensifying US-Iran conflict and US President Donald Trump’s new tariffs temper investors’ appetite for riskier assets. Japan’s Nikkei N225 is down nearly 3% while South Korea’s KOSPI declined over 4.5%, underperforming broader markets. The US military announced that it has completed another round of strikes…
Eli Lilly (LLY +0.76%) was second to market with a GLP-1 weight-loss drug, losing out to Novo Nordisk (NVO 2.31%). However, Eli Lilly’s Mounjaro and Zepbound produce stronger weight-loss results than Novo Nordisk’s Wegovy, and they quickly took the lead. Now, many on Wall Street see Eli Lilly as a GLP-1 stock, which it is….